Abdelmonem Awad Hegazy, MBBCH with honor, MD
Professor of Human Anatomy and Embryology,, Faculty of Medicine
Zagazig University, Egypt
Dr. Abdelmonem A. Hegazy is currently working as Professor of Human Anatomy and Embryology, Faculty of Medicine, Zagazig University, Egypt & College of Biotechnology, Misr University for Science & Technology (MUST), Egypt. He is also a Consultant of Obstetrics, Gynecology and Infertility. He is the former chairman of the Anatomy and Embryology Department, Faculty of Medicine, Zagazig University (Egypt); & Professor in King Saud and Majmaah Universities (KSA) 2009-2013 and Misurata, Faculty of Medicine (Libya) 2000. Dr. Hegazy is also a referee of scientific research submitted for promotion of professors in Egyptian Universities (since 2016 till Present). Prof Hegazy is a Global Goodwill Ambassador (GGA). He is also an Egyptian Ambassador for International Program for Prevention of Child Abuse ‘My Body is My Body’.
Basic medical sciences, Anatomy, Embryology, Stem cell research and therapy, Neonatology, Trauma, Emergency, Osteology, Neuroanatomy, Histology, Histopathology, Infections, Infertility, Gynecology, Obstetrics, Genetics and Congenital anomalies.
Mitsuo Oshimura, PhD
Professor, Director of Chromosome Engineering Research Center (CERC), Institute of Regenerative Medicine and Biofunction
Tottori University, Japan
Mitsuo Oshimura is a Professor at the Department of Biomedical Science, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Science, Tottori University.
Oshimura started to study on chromosome abnormalities of human cancer and leukemia, and found several common aneuploidy and chromosome translocations in certain types of cancer and leukemia at RMPI, USA. Dr. Oshimura has developed human artificial chromosomes(HACs) for use as gene delivery vectors to overcome various problems in existing viral and non-viral vector systems. Dr. Oshimura is also involved in developing various new and ideal HACs that will be useful for designing HAC-based gene and cell therapies, as well for humanized animal models.